Synta reports $10.3M net loss for third quarter 2010 vs. $118.1M net income for third
 

Synta Pharmaceuticals Corp., a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical conditions, today reported financial results and operational highlights for the quarter ended September 30, 2010.

More...